[Türkçe]

Turkish Society of Cardiology Young Cardiologists Bulletin Year: 5 Number: 4 / 2022


Turkish Society of Cardiology
Young Cardiologists
President
Dr. Muzaffer Değertekin

Coordinator for the
Board of Directors

Dr. Ertuğrul Okuyan

Coordinator for the
Board of Directors

Dr. Can Yücel Karabay

Members
Dr. Adem Aktan
Dr. Gülşah Aktüre
Dr. Bayram Arslan
Dr. İnanç Artaç
Dr. Ahmet Oğuz Aslan
Dr. Görkem Ayhan
Dr. Ahmet Anıl Başkurt
Dr. Özkan Bekler
Dr. Oğuzhan Birdal
Dr. Yusuf Bozkurt Şahin
Dr. Serkan Bulgurluoğlu
Dr. Ümit Bulut
Dr. Veysi Can
Dr. Mustafa Candemir
Dr. Murat Çap
Dr. Göksel Çinier
Dr. Ali Çoner
Dr. Yusuf Demir
Dr. Ömer Furkan Demir
Dr. Murat Demirci
Dr. Ayşe İrem Demirtola Mammadli
Dr. Süleyman Çağan Efe
Dr. Mehmet Akif Erdöl
Dr. Kubilay Erselcan
Dr. Kerim Esenboğa
Dr. Duygu Genç
Dr. Kemal Göçer
Dr. Elif Güçlü
Dr. Arda Güler
Dr. Duygu İnan
Dr. Hasan Burak İşleyen
Dr. Muzaffer Kahyaoğlu
Dr. Sedat Kalkan
Dr. Yücel Kanal
Dr. Özkan Karaca
Dr. Ahmet Karaduman
Dr. Mustafa Karanfil
Dr. Ayhan Kol
Dr. Fatma Köksal
Dr. Mevlüt Serdar Kuyumcu
Dr. Yunus Emre Özbebek
Dr. Ahmet Özderya
Dr. Yasin Özen
Dr. Ayşenur Özkaya İbiş
Dr. Çağlar Özmen
Dr. Selvi Öztaş
Dr. Hasan Sarı
Dr. Serkan Sivri
Dr. Ali Uğur Soysal
Dr. Hüseyin Tezcan
Dr. Nazlı Turan
Dr. Berat Uğuz
Dr. Örsan Deniz Urgun
Dr. İdris Yakut
Dr. Mustafa Yenerçağ
Dr. Mehmet Fatih Yılmaz
Dr. Yakup Yiğit
Dr. Mehmet Murat Yiğitbaşı

Bulletin Editors
Dr. Muzaffer Değertekin
Dr. Bülent Mutlu
Dr. Göksel Çinier
Dr. Süleyman Çağan Efe
Dr. Duygu İnan

Contributors
Dr. Erdi Babayiğit
Dr. Bengisu Keskin Meriç
Dr. Muammer Karakayalı
Dr. Ekrem Şahan


 



4--12

Heart Team decision-making based on angiography-derived FFR: DECISION QFRTürk Kardiyoloji Derneği Genç Kardiyologlar Bülteni - Heart Team decision-making based on angiography-derived FFR: DECISION QFR (Dr. Erdi Babayiğit)

Reviewer: Dr. Erdi Babayiğit

Name of the Study: Heart Team decision-making based on angiography-derived FFR: DECISION QFR

Published Congress: EuroPCR 2022

Background: Functional SYNTAX Score (FSS) assessment has shown that physiological assessment is better than anatomical assessment alone in predicting clinical outcomes in patients with multivessel disease to be revascularized. Quantitative flow reserve (QFR) is a simulation of FFR based on angiographic images, facilitating the evaluation of FSS without the need for a pressure wire or pharmacological hyperemia.

Objectives: The DECISION QFR study investigated the feasibility of the QFR in terms of providing physiological information to the cardiac team in deciding the optimal revascularization strategy in patients with multivessel disease.

Methods: The DECISION QFR study is a prospective, randomized clinical trial conducted at 10 different centers in Japan, involving 260 patients with 2 or 3 vessel disease including proximal LAD lesion and with chronic coronary syndromes eligible for revascularization. Patients were evaluated by two different heart teams consisting of interventional cardiologist and cardiac surgeon. Both teams evaluated anatomical SYNTAX score, functional SYNTAX score created with either QFR or FFR, and FSS-based SYNTAX II 2020 scoring in terms of percutaneous intervention or coronary artery bypass graft operation. The primary endpoint of the study was the decision-making situation in which both heart teams agreed as “CABG only” or “equipoise (CABG or PCI) or PCI only”, and decision agreement was evaluate by the Cohen’ ?. index. (? >0.60: substantial agreement). The secondary endpoints were agreement in vessel to be treated and mean procedural times.

Results: Among the patients who met the inclusion criteria in the study, the mean age of 248 patients was 70.9 (± 10.2), 48.4% had diabetes, 41.9% had the 2-vessel disease, and 58.1% had the 3-vessel disease. The mean anatomical SYNTAX score of the patients was 20.9 ± 9.3.
The correlation between QFR and FFR was high. (Pearson R=0.68). 91.5% agreement was observed between the tertiles of FSS evaluated according to QFR (FSSQFR) and FSS evaluated according to FFR (FSSFFR). (intraclass correlation coefficient (ICC) = 0.94 [0.93-0.95]). There was also a high rate of agreement between the QFR and FFR groups in the SYNTAX II 2020 scoring system, which evaluates the 10-year mortality after PCI (ICC = 0.998 [0.998-0.999]).
Cohen’s kappa value was 0.73 as “significant agreement” in the agreement of treatment recommendations.
As a secondary endpoint, the rate of agreement at vessel level to be treated or not with PCI or CABG recommendation was 86.1% in the PCI group and 88.0% in the CABG group, according to the QFR and FFR. (Cohen’s Kappa value for both: 0.72)
The other secondary endpoint, mean total procedure time was shorter in the QFR group than in the FFR group. (p =0.035 for total, p<0.001 for prespecified angiographic protocol)

Conclusion: In patients with multivessel disease, QFR-based scoring versus FFR-based scoring showed substantial agreement in treatment decision making by the cardiac team. There was an almost perfect agreement between the QFR-based SYNTAX and SYNTAX II 2020 scores and the FFR-based scores. Considering the prospective angiography times, QFR has a shorter procedure time compared to FFR.

Interpretations:  In addition to the anatomical SYNTAX score, functional SYNTAX scores provide more information to the cardiac team in terms of clinical outcomes in the decision-making process in multi-vessel patients. Among the handicaps of FFR in functional scoring are possible vessel damage by the pressure wire and an increase in the duration of the procedure. Compared to the FFR, the QFR does not require additional manipulation and has a shorter time in the angiography plan and is more advantageous, besides, it shows clinical compatibility in decision making with FFR. The easy applicability of the QFR may increase the applicability of physiology guidance for optimal revascularization in clinical decision making.


4--12

 2024 © Turkish Society of Cardiology.